Tezosentan
Tezosentan is a synthetic endothelin receptor antagonist that has been studied for its potential therapeutic effects in treating acute heart failure and other cardiovascular conditions. It works by blocking the action of endothelin, a potent vasoconstrictor peptide that plays a significant role in the pathophysiology of various cardiovascular diseases.
Mechanism of Action[edit]
Tezosentan is a dual endothelin receptor antagonist, meaning it inhibits both endothelin receptor type A (ETA) and endothelin receptor type B (ETB). By blocking these receptors, tezosentan prevents endothelin from exerting its vasoconstrictive and proliferative effects on the vascular smooth muscle cells, leading to vasodilation and reduced vascular resistance.
Clinical Applications[edit]
Tezosentan has been primarily investigated for its use in acute heart failure. Clinical trials have explored its efficacy in improving hemodynamic parameters and reducing symptoms associated with heart failure. However, results have been mixed, and its use in clinical practice remains limited.
Acute Heart Failure[edit]
In patients with acute heart failure, tezosentan has been shown to improve cardiac output and reduce pulmonary capillary wedge pressure. Despite these hemodynamic benefits, some studies have not demonstrated a significant improvement in clinical outcomes, such as mortality or hospitalization rates.
Pharmacokinetics[edit]
Tezosentan is administered intravenously due to its poor oral bioavailability. It has a rapid onset of action, with peak plasma concentrations achieved within minutes of administration. The drug is metabolized primarily in the liver and excreted in the urine.
Side Effects[edit]
Common side effects of tezosentan include hypotension, headache, and nausea. Due to its potent vasodilatory effects, it can also cause flushing and dizziness. Monitoring of blood pressure and renal function is recommended during treatment.
Research and Development[edit]
Tezosentan continues to be a subject of research, particularly in the context of cardiovascular diseases. Ongoing studies aim to better understand its potential benefits and limitations in various clinical settings.
See Also[edit]
References[edit]
External Links[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
